Cardinal, McKesson Incentives Are At Center Of Bristol Restatement
Executive Summary
Bristol's revised approach to accounting for excess inventory leaves the company room to offer trade incentives in the future
You may also be interested in...
Bristol $300 Mil. DoJ Settlement Includes Separation OF CEO/Chairman Roles
Bristol-Myers Squibb board member James Robinson will take on additional corporate governance oversight responsibilities, including meeting with execs prior to analyst calls, as the newly-appointed chairman
Direct Distribution Would Cut Manufacturer Margins By 12% – HDMA Study
Pharmaceutical manufacturers would incur $10.5 bil. in costs if they attempt to replace wholesalers with direct distribution operations offering the same level of service, a report commissioned by the Healthcare Distribution Management Association states
Direct Distribution Would Cut Manufacturer Margins By 12% – HDMA Study
Pharmaceutical manufacturers would incur $10.5 bil. in costs if they attempt to replace wholesalers with direct distribution operations offering the same level of service, a report commissioned by the Healthcare Distribution Management Association states